Fact CheckerSign in

NCT07541456CompletedPhase 4

Empagliflozin Versus Non-SGLT2 Oral Drugs for Blood Pressure in Type 2 Diabetes

Comparison of Mean Blood Pressure in Patients With Type 2 Diabetes Mellitus Treated With Empagliflozin Versus Non-SGLT2 Oral Hypoglycemic Agents: A Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 21 Apr 2026

Brief summary (registry, in English)

This randomized controlled trial studied whether empagliflozin lowers blood pressure better than non-SGLT2 oral hypoglycemic treatment in adults with type 2 diabetes mellitus and hypertension. A total of 300 participants were assigned to 1 of 2 treatment groups and followed for 12 weeks. One group received empagliflozin and the other received non-SGLT2 oral therapy. Blood pressure was measured at baseline and again after 12 weeks to compare the effect of treatment on systolic and diastolic blood pressure.

Status (registry)
Completed
Phase (registry)
Phase 4
Study type
Interventional
Enrollment
300 (actual)
First submitted
9 Apr 2026
Start date
Jun 2025
Primary completion date
Nov 2025
Lead sponsor
Dr. Zarmina Younes
NCT number
NCT07541456

What you commit to

  • Study type: Interventional · Phase 4
  • Participants enrolled: 300
  • From Jun 2025 to the primary completion date, Nov 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Heart failure Chronic renal failure Pregnant women History of hypertension preceding type 2 diabetes mellitus by more than 6 months

Who the study is looking for

  • Adults aged 20 to 70 years Either male or female Type 2 diabetes mellitus for more than 3 months Hypertension for more than 3 months

Age in the registry: 20 years to 70 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Shahida Islam Medical College, Lodhran
Coordinator of this site? Confirm its status
LodhranPakistanUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.